I would stop sulfonylurea due to risk of hypoglycemia and DPP IV. I would continue metformin and add a GLP 1 to help with weight loss and cardiovascular protection.
-
Leonardo Que4yrI would discontinue the Sulfonylurea and DPP4 since she is not achieving the goal, I would recommend putting her on SGLT2 Inhibitor which has proven benefits on the kidney, CHF, Show More
Atherogenic index of plasma is associated with major adverse cardiovascular events in patients with type 2 diabetes mellitus
Source : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493717/
Atherosclerotic cardiovascular disease (ASCVD) refers to a condition that involves cholesterol buildup in the arteries, often presenting as coronary heart disease, cerebrovascular disease, and peripheral artery disease of atherosclerotic origin....
-
Type 2 Diabetes Connect4yrKey Points • Source: Cardiovascular Diabetology • Conclusion/Relevance: “This study showed that AIP [atherogenic index of plasma] might be a strong biomarker that could be used to predict the risk of cardiovascular Show More
Major adverse limb events in type 2 diabetes patients receiving glucagon-like peptide-1 receptor agonists versus sodium-glucose cotransporter 2 inhibitors: A retrospective multi-institutional study - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/34599973/
1 Division of Cardiology, Department of Internal Medicine, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taipei, Taiwan, 199 Tun-Hwa North Road, Taipei 105, Taiwan. 2 Division of...
Proteinuria as a Significant Predictive Factor for the Progression of Carotid Artery Atherosclerosis in Non-Albuminuric Type 2 Diabetes - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/34627943/
doi: 10.1016/j.diabres.2021.109082. Online ahead of print. 1 Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea. 2 Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea....